Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I., Uray, I., Wu, X., Brown, P., Shen, X., Mills, G., Peng, G.: ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discovery 5 (7), 752-767, 2015.
Uray, I., Dmitrovsky, E., Brown, P.: Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic. Semin. Oncol. 43 (1), 49-64, 2016.
Zhang, L., Peng, Y., Uray, I., Shen, J., Wang, L., Peng, X., Brown, P., Tu, W., Peng, G.: Natural product [beta]-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. DNA Repair. 60 89-101, 2017.
Chowdhury, P., Powell, R., Stephan, C., Uray, I., Talley, T., Karki, M., Tripathi, D., Park, Y., Mancini, M., Davies, P., Dere, R.: Bexarotene: a Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells. J. Cell Sci. 131 1-12, 2018.
Kocsis, J., Szekanecz, É., Bassam, A., Uhlyarik, A., Pápai, Z., Rubovszky, G., Mezősi, E., Rucz, K., Garai, I., Nagy, E., Uray, I., Horváth, Z.: First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: efficacy and Safety Analysis. Exp. Clin. Endocrinol. Diabetes. 127 (4), 240-246, 2019.
Uray, I., Uray, K.: Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface. Int. J. Mol. Sci. 22 (21), 1-23, 2021.
Jdeed, S., Erdős, E., Bálint, B., Uray, I.: The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling. Mol. Cancer Res. 20 (7), 1071-1082, 2022.
Jdeed, S., Lengyel, M., Uray, I.: Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-[béta] Signaling. Cells. 11 (17), 1-15, 2022.
Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death. Cell Death Dis. 14 (3), 1-10, 2023.
Lengyel M., Molnár Á., Nagy T., Jdeed S., Garai I., Horváth Zs., Uray, I.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix. Cancer Sci. 2025 Jan;116(1):81-94. doi: 10.1111/cas.16382.
Lengyel M., Árkosy P., Uray, I.: G protein subtype preference dictates paroxetine-enhanced serotonin receptor response in non-malignant breast epithelial cells. Biochem Pharm, in press